Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Meta Biomed Co Ltd Issues FY 2013 Outlook


Tuesday, 21 May 2013 09:23pm EDT 

Meta Biomed Co Ltd announced that it expects its fiscal year 2013 revenue and operating profit to record KRW 37.8 billion and KRW 6 billion, respectively. 

Latest Developments for Metabiomed Co Ltd

Company Quote

3135.0
-70.0 -2.18%
22 Sep 2014